Nasopharyngeal Diseases

Pathological processes involving the NASOPHARYNX.

Also Known As:

Diseases of Nasopharynx; Disease, Nasopharyngeal; Diseases, Nasopharyngeal; Nasopharyngeal Disease; Nasopharynx Disease; Nasopharynx Diseases

Networked: 15 relevant articles (2 outcomes, 2 trials/studies)

Relationship Network

Disease Context: Research Results

Stomatognathic Diseases: 705
- Pharyngeal Diseases: 21
  - Nasopharyngeal Diseases: 15
    - Nasopharyngeal Neoplasms: 1312
    - Nasopharyngitis: 530
Otorhinolaryngologic Diseases: 203
- Pharyngeal Diseases: 21
  - Nasopharyngeal Diseases: 15
    - Nasopharyngeal Neoplasms: 1312
    - Nasopharyngitis: 530

Related Diseases

1.	Otitis Media
2.	Oropharyngeal Neoplasms
3.	Neoplasms (Cancer)
4.	Carcinoma (Carcinomatosis)
5.	Infectious Mononucleosis (Glandular Fever)

Experts

1.	Ascenso, Andreia: 1 article (11/2021)
2.	Calvo, Esteban: 1 article (11/2021)
3.	Casula, Eleonora: 1 article (11/2021)
4.	Lopez-Mendez, Tania Belen: 1 article (11/2021)
5.	Lozano, Antonio: 1 article (11/2021)
6.	Manca, Maria Letizia: 1 article (11/2021)
7.	Manconi, Maria: 1 article (11/2021)
8.	Pedraz, José Luis: 1 article (11/2021)
9.	Vázquez, José Antonio: 1 article (11/2021)
10.	Zaru, Marco: 1 article (11/2021)

Drugs and Biologics

Drugs and Important Biological Agents (IBA) related to Nasopharyngeal Diseases:

1.	VaccinesIBA 11/01/2008 - "Every country should have its own strong and sustained surveillance system implemented to monitor the effects of vaccination on the frequency of vaccine and nonvaccine serotypes for invasive or mucosal disease, nasopharyngeal carriage and the indirect effects before and after introduction of PCV. " 08/01/1999 - "It would seem reasonable to suggest that emerging technologies are at a level where vaccine trials aimed at controlling infectious mononucleosis, post-transplant lymphoproliferative disease, nasopharyngeal carcinoma and Hodgkin's disease are justified. " 04/01/1998 - "Studies to assess vaccine efficacy of PNCRM7 for prevention of systemic disease, nasopharyngeal colonization, and acute otitis media are in progress. "
2.	Heptavalent Pneumococcal Conjugate Vaccine (Prevnar)IBA 04/01/1998 - "Studies to assess vaccine efficacy of PNCRM7 for prevention of systemic disease, nasopharyngeal colonization, and acute otitis media are in progress. "
3.	Cisplatin (Platino)FDA LinkGeneric 06/15/2008 - "Concomitant cisplatin-based chemotherapy and radiotherapy is the strategy that has proven most effective for organ preservation for larynx and oropharynx cancers, the treatment of unresectable disease, nasopharyngeal cancer and the post-operative adjuvant treatment of patients at high risk of recurrence. "
4.	Nasal SpraysIBA 11/04/2021 - "halicacabum) obtained from flower, leaf and vine was loaded into modified phospholipid vesicles aiming at obtaining sprayable, biocompatible and effective nasal spray formulations for the treatment of nasopharyngeal diseases. "
5.	ChemokinesIBA 07/01/2012 - "During course of disease, nasopharyngeal concentrations of most cytokines and chemokines decreased, reaching statistical significance for IL-6 and IP-10. "
6.	CytokinesIBA 07/01/2012 - "During course of disease, nasopharyngeal concentrations of most cytokines and chemokines decreased, reaching statistical significance for IL-6 and IP-10. "
7.	Interleukin-6 (Interleukin 6)IBA 07/01/2012 - "During course of disease, nasopharyngeal concentrations of most cytokines and chemokines decreased, reaching statistical significance for IL-6 and IP-10. "
8.	RadiumIBA 07/09/1950 - "[Treatment of certain nasopharyngeal diseases with the radium emanator]."
9.	Phospholipids (Phosphatides)FDA LinkGeneric 11/04/2021 - "halicacabum) obtained from flower, leaf and vine was loaded into modified phospholipid vesicles aiming at obtaining sprayable, biocompatible and effective nasal spray formulations for the treatment of nasopharyngeal diseases. "
10.	Immunoglobulin G (IgG)IBA 01/01/2016 - "Correspondingly, the levels of serum Rta-IgG in NPC patients (3.05, 1.19-4.95) were significantly higher than those of non-NPC participants (0.15, 0.08-0.30, P< 0.05) including the patients with lung cancer (0.14, 0.08-0.19), the patients with breast carcinoma (0.17, 0.10-0.25), the patients with gastric carcinoma (0.08, 0.05-0.16), the patients with malignant lymphoma (0.13, 0.08-0.20), the patients with benign nasopharyngeal disease (1.65, 0.74-1.93) and healthy volunteers (0.22, 0.13-0.32), respectively. "

Therapies and Procedures

1.	Radiotherapy 03/01/1980 - "Principles of radiotherapy are expounded and a more diligent search for detecting nasopharyngeal disease is proposed." 03/01/1999 - "The initial nasopharyngeal disease for which radiotherapy was indicated was nasopharyngeal carcinoma (six patients) and nasopharyngeal lymphoma (one patient). " 06/15/2008 - "Concomitant cisplatin-based chemotherapy and radiotherapy is the strategy that has proven most effective for organ preservation for larynx and oropharynx cancers, the treatment of unresectable disease, nasopharyngeal cancer and the post-operative adjuvant treatment of patients at high risk of recurrence. "
2.	Drug Therapy (Chemotherapy) 06/15/2008 - "Concomitant cisplatin-based chemotherapy and radiotherapy is the strategy that has proven most effective for organ preservation for larynx and oropharynx cancers, the treatment of unresectable disease, nasopharyngeal cancer and the post-operative adjuvant treatment of patients at high risk of recurrence. "
3.	Transplantation 05/01/2023 - "EBV is a major causative agent of Burkitt lymphoma, Hodgkin lymphoma, post-transplantation lymphoproliferative disorder, NK/T cell lymphoma, chronic active EBV disease, nasopharyngeal carcinoma, gastric carcinoma, and infectious mononucleosis. "
4.	Adenoidectomy 08/01/1998 - "To determine the type of acoustic rhinometry curve in different kinds of nasal and nasopharyngeal diseases and the role of acoustic rhinometry in the evaluation of the changes of the volume of nasopharynx before and after adenoidectomy. "